European Companies Search Engine
EU funding (€2,999,498): Overcoming Clinical Relapse in Multiple Myeloma by Understanding and Targeting the Molecular Causes of Drug Resistance Fts 1 Jan 2012 Financial Transparency System
Overview
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state.